Anders Ekblom

Insider Reports History

Entity
Individual
Location
C/O Mereo Biopharma, 1 Cavendish Place, London, United Kingdom
Signature
/s/ Christine Fox, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anders Ekblom:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mereo BioPharma Group plc Director Share Options (Right to buy) 45K $45.5K $1.01 Feb 8, 2024 Direct
Mereo Biopharma Group plc Director American Depositary Shares representing Ordinary Shares 37.9K $38.3K $1.01 Jan 1, 2024 By Nxt Science AB
Mereo BioPharma Group plc Director Deferred Restricted Stock Units 19.5K Feb 8, 2024 Direct

Insider Reports Filed by Anders Ekblom

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MREO Mereo BioPharma Group plc Feb 8, 2024 2 $0 4 Feb 9, 2024 Director
MREO Mereo Biopharma Group plc Jan 1, 2024 0 $0 3 Jan 2, 2024 Director